Search Results - "Freeman, James V"

National Trends in Atrial Fibrillation Hospitalization, Readmission, and Mortality for Medicare Beneficiaries, 1999–2013 by Freeman, James V, Wang, Yun, Akar, Joseph, Desai, Nihar, Krumholz, Harlan

“…BACKGROUND:Data are lacking on national trends for atrial fibrillation (AF) hospitalization, particularly with regard to long-term outcomes including…”
Get full text

The NCDR Left Atrial Appendage Occlusion Registry by Freeman, James V., Varosy, Paul, Price, Matthew J., Slotwiner, David, Kusumoto, Fred M., Rammohan, Chidambaram, Kavinsky, Clifford J., Turi, Zoltan G., Akar, Joseph, Koutras, Cristina, Curtis, Jeptha P., Masoudi, Frederick A.

“…Left atrial appendage occlusion (LAAO) to prevent stroke in patients with atrial fibrillation has been evaluated in 2 randomized trials; post-approval clinical…”
Get full text

Clinical Impact of Residual Leaks Following Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry by Alkhouli, Mohamad, Du, Chengan, Killu, Ammar, Simard, Trevor, Noseworthy, Peter A, Friedman, Paul A, Curtis, Jeptha P, Freeman, James V, Holmes, David R

“…Data on the impact of residual peri-device leak after left atrial appendage occlusion (LAAO) are limited. The goal of this study was to explore the association…”
Get full text

Procedural Complications, Rehospitalizations, and Repeat Procedures After Catheter Ablation for Atrial Fibrillation by Shah, Rashmee U., MD, MS, Freeman, James V., MD, MPH, Shilane, David, PhD, Wang, Paul J., MD, Go, Alan S., MD, Hlatky, Mark A., MD

“…Objectives The purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat…”
Get full text

Feasibility of Amulet occluder implantation after failed left atrial appendage occlusion attempt: Insights from the EMERGE LAA postapproval study by Makkar, Akash, Alkhouli, Mohamad, Ellis, Christopher R., Shah, Atman P., Coylewright, Megan, Freeman, James V., Anderson, Jordan A., Gage, Ryan, Lakkireddy, Dhanunjaya

“…Although expertise in left atrial appendage occlusion (LAAO) has grown, certain intricate anatomies may pose challenges, rendering them unsuitable for LAAO…”
Get full text

First Experience With Amulet in the United States: Early Insights From EMERGE LAA Postapproval Study by Alkhouli, Mohamad, Freeman, James V, Ellis, Christopher R, Shah, Atman P, Gada, Hemal, Coylewright, Megan, Lo, Monica, Makkar, Akash, Agarwal, Himanshu, Lakkireddy, Dhanunjaya

“…The Food and Drug Administration approved the Amulet occluder (Abbott) after demonstrating safety and effectiveness in the Amulet IDE (AMPLATZER Amulet LAA…”
Get full text

Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation—Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) by Holmqvist, Fredrik, MD, PhD, Guan, Ni, MS, Zhu, Zhaoyin, MS, Kowey, Peter R., MD, Allen, Larry A., MD, MHS, Fonarow, Gregg C., MD, Hylek, Elaine M., MD, MPH, Mahaffey, Kenneth W., MD, Freeman, James V., MD, MPH, MS, Chang, Paul, MD, Holmes, DaJuanicia N., MS, Peterson, Eric D., MD, MPH, Piccini, Jonathan P., MD, MHS, Gersh, Bernard J., MB, ChB, DPhil

“…Background Obstructive sleep apnea (OSA) is common in patients with atrial fibrillation (AF). Little is known about the impact of OSA on AF treatment and…”
Get full text

Anticoagulation Alone vs Anticoagulation Plus Aspirin or DAPT Following Left Atrial Appendage Occlusion by Reinhardt, Samuel W., Gibson, Douglas N., Hsu, Jonathan C., Kapadia, Samir R., Yeh, Robert W., Price, Matthew J., Piccini, Jonathan P., Nair, Devi G., Christen, Thomas, Allocco, Dominic J., Freeman, James V.

“…The prevalence of and outcomes associated with different antithrombotic strategies after left atrial appendage occlusion (LAAO) are not well described. This…”
Get full text

Frequency and Outcomes of Reduced Dose Non–Vitamin K Antagonist Anticoagulants: Results From ORBIT‐AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II) by Steinberg, Benjamin A., Shrader, Peter, Pieper, Karen, Thomas, Laine, Allen, Larry A., Ansell, Jack, Chan, Paul S., Ezekowitz, Michael D., Fonarow, Gregg C., Freeman, James V., Gersh, Bernard J., Kowey, Peter R., Mahaffey, Kenneth W., Naccarelli, Gerald V., Reiffel, James A., Singer, Daniel E., Peterson, Eric D., Piccini, Jonathan P.

“…Background Non–vitamin K antagonist oral anticoagulants (NOACs) are indicated for stroke prevention in atrial fibrillation (AF) but require lower doses in…”
Get full text

Development and validation of an automated algorithm for end point adjudication for a large U.S. national registry by Friedman, Daniel J., Pierre, Dominique, Wang, Yongfei, Gambone, Louise, Koutras, Christina, Segawa, Claire, Farb, Andrew, Vemulapalli, Sreekanth, Varosy, Paul D., Masoudi, Frederick A., Lansky, Alexandra, Curtis, Jeptha P., Freeman, James V.

“…Clinical events committee (CEC) evaluation is the standard approach for end point adjudication in clinical trials. Due to resource constraints, large…”
Get full text

Periprocedural Pericardial Effusion Complicating Transcatheter Left Atrial Appendage Occlusion: A Report From the NCDR LAAO Registry by Price, Matthew J., Valderrábano, Miguel, Zimmerman, Sarah, Friedman, Daniel J., Kar, Saibal, Curtis, Jeptha P., Masoudi, Frederick A., Freeman, James V.

“…Pericardial effusion (PE) is a potential complication of transcatheter left atrial appendage occlusion. The objective of this study was to investigate the…”
Get full text

Digoxin Use and Associated Adverse Events Among Older Adults by Angraal, Suveen, Nuti, Sudhakar V., Masoudi, Frederick A., Freeman, James V., Murugiah, Karthik, Shah, Nilay D., Desai, Nihar R., Ranasinghe, Isuru, Wang, Yun, Krumholz, Harlan M.

“…Over the past 2 decades, guidelines for digoxin use have changed significantly. However, little is known about the national-level trends of digoxin use,…”
Get full text

B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation by Inohara, Taku, Kim, Sunghee, Pieper, Karen, Blanco, Rosalia G, Allen, Larry A, Fonarow, Gregg C, Gersh, Bernard J, Ezekowitz, Michael D, Kowey, Peter R, Reiffel, James A, Naccarelli, Gerald V, Chan, Paul S, Mahaffey, Kenneth W, Singer, Daniel E, Freeman, James V, Steinberg, Benjamin A, Peterson, Eric D, Piccini, Jonathan P

“…The association with B-type natriuretic peptide (BNP), disease progression and outcomes in patients with atrial fibrillation (AF) has not been thoroughly…”
Get more information

Abnormal left atrial body stiffness is predicted by appendage size: impact of appendage occlusion on left atrial mechanics assessed by pressure-volume analysis by Bregasi, Alda, Freeman, James V, Curtis, Jeptha P, Akar, Joseph G, Ortiz-Leon, Xochitl A, Maia, Julia H, Higgins, Angela Y, Matthews, Ray V, Sinusas, Albert J, McNamara, Robert L, Sugeng, Lissa, Lin, Ben A

“…Atrial cardiomyopathy has been recognized as having important consequences for cardiac performance and clinical outcomes. The pathophysiological role of the…”
Get more information

Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation by Freeman, James V, Shrader, Peter, Pieper, Karen S, Allen, Larry A, Chan, Paul S, Fonarow, Gregg C, Gersh, Bernard J, Kowey, Peter R, Mahaffey, Kenneth W, Naccarelli, Gerald, Reiffel, James A, Singer, Daniel E, Go, Alan S, Hylek, Elaine M, Steinberg, Benjamin A, Peterson, Eric D, Piccini, Jonathan P

“…BACKGROUND:Studies evaluating the effects of atrial fibrillation (AF) catheter ablation versus antiarrhythmic therapy on outcomes have shown mixed results. In…”
Get full text

Survival Following Implantable Cardioverter-Defibrillator Implantation in Patients With Amyloid Cardiomyopathy by Higgins, Angela Y, Annapureddy, Amarnath R, Wang, Yongfei, Minges, Karl E, Lampert, Rachel, Rosenfeld, Lynda E, Jacoby, Daniel L, Curtis, Jeptha P, Miller, Edward J, Freeman, James V

“…Background Outcomes data in patients with cardiac amyloidosis after implantable cardioverter-defibrillator (ICD) implantation are limited. We compared outcomes…”
Get full text

Feasibility of Extended Ambulatory Electrocardiogram Monitoring to Identify Silent Atrial Fibrillation in High‐risk Patients: The Screening Study for Undiagnosed Atrial Fibrillation (STUDY‐AF) by Turakhia, Mintu P., Ullal, Aditya J., Hoang, Donald D., Than, Claire T., Miller, Jared D., Friday, Karen J., Perez, Marco V., Freeman, James V., Wang, Paul J., Heidenreich, Paul A.

“…ABSTRACT Background Identification of silent atrial fibrillation (AF) could prevent stroke and other sequelae. Hypothesis Screening for AF using continuous…”
Get full text

Intracardiac vs Transesophageal Echocardiography for Left Atrial Appendage Occlusion With Watchman FLX in the U.S by Ferro, Enrico G, Alkhouli, Mohamad, Nair, Devi G, Kapadia, Samir R, Hsu, Jonathan C, Gibson, Douglas N, Freeman, James V, Price, Matthew J, Roy, Kristine, Allocco, Dominic J, Yeh, Robert W, Piccini, Jonathan P

“…Intraprocedural imaging is critical for device delivery in transcatheter left atrial appendage occlusion (LAAO). Although pivotal trials of LAAO devices were…”
Get full text

National Trends in the Burden of Atrial Fibrillation During Hospital Admissions for Heart Failure by Reinhardt, Samuel W, Chouairi, Fouad, Miller, P Elliott, Clark, Katherine A A, Kay, Bradley, Fuery, Michael, Guha, Avirup, Freeman, James V, Ahmad, Tariq, Desai, Nihar R, Friedman, Daniel J

“…Background Heart failure (HF) and atrial fibrillation (AF) frequently coexist and may be associated with worse HF outcomes, but there is limited contemporary…”
Get full text

Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation by Hess, Paul L., MD, MHS, Kim, Sunghee, PhD, Fonarow, Gregg C., MD, Thomas, Laine, PhD, Singer, Daniel E., MD, Freeman, James V., MD, MPH, Gersh, Bernard J., MB, ChB, DPhil, Ansell, Jack, MD, Kowey, Peter R., MD, Mahaffey, Kenneth W., MD, Chan, Paul S., MD, MSc, Steinberg, Benjamin A., MD, MHS, Peterson, Eric D., MD, MPH, Piccini, Jonathan P., MD, MHS

“…Background Prior studies have shown a treatment gap in oral anticoagulation (OAC) use among patients with atrial fibrillation yet have incompletely…”
Get full text